Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Li Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9678-9653; OpenAlex author ID A5100418871. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress. First author DOI 10.3390/ijms262110694↗
  2. Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1. Co-author DOI 10.1038/cddis.2017.455↗
  3. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Co-author DOI 10.1002/ijc.28583↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wuli Zhao · 1 shared paper, 2025 · strength 0.27
  2. Zixiang Gao · 1 shared paper, 2025 · strength 0.27
  3. Ting Zhao · 1 shared paper, 2025 · strength 0.27
  4. Nathalie Bauer · 2 shared papers, 2014–2017 · strength 0.10
  5. Clifford C. Nwaeburu · 2 shared papers, 2014–2017 · strength 0.10
  6. Ingrid Herr · 2 shared papers, 2014–2017 · strength 0.10
  7. Thilo Hackert · 1 shared paper, 2017 · strength 0.06
  8. Oliver Strobel · 1 shared paper, 2017 · strength 0.06
  9. Peter Schemmer · 1 shared paper, 2014 · strength 0.04
  10. Jens Werner · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.